Search

Your search keyword '"Sercia, Linda"' showing total 20 results
Start Over Author "Sercia, Linda"
20 results on '"Sercia, Linda"'

7. Reply to “Risks of ‘Blind' Automated Identification Systems in Medical Microbiology”

Author

Westblade, Lars F., primary, Jennemann, Rebecca, additional, Branda, John A., additional, Bythrow, Maureen, additional, Ferraro, Mary Jane, additional, Garner, Omai B., additional, Ginocchio, Christine C., additional, Lewinski, Michael A., additional, Manji, Ryhana, additional, Mochon, A. Brian, additional, Procop, Gary W., additional, Richter, Sandra S., additional, Rychert, Jenna A., additional, Sercia, Linda, additional, and Burnham, Carey-Ann D., additional

Published
2013
Full Text
View/download PDF

9. Multicenter Evaluation of the Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System for Identification of Gram-Positive Aerobic Bacteria

Author

Rychert, Jenna, primary, Burnham, Carey-Ann D., additional, Bythrow, Maureen, additional, Garner, Omai B., additional, Ginocchio, Christine C., additional, Jennemann, Rebecca, additional, Lewinski, Michael A., additional, Manji, Ryhana, additional, Mochon, A. Brian, additional, Procop, Gary W., additional, Richter, Sandra S., additional, Sercia, Linda, additional, Westblade, Lars F., additional, Ferraro, Mary Jane, additional, and Branda, John A., additional

Published
2013
Full Text
View/download PDF

10. Multicenter Study Evaluating the Vitek MS System for Identification of Medically Important Yeasts

Author

Westblade, Lars F., primary, Jennemann, Rebecca, additional, Branda, John A., additional, Bythrow, Maureen, additional, Ferraro, Mary Jane, additional, Garner, Omai B., additional, Ginocchio, Christine C., additional, Lewinski, Michael A., additional, Manji, Ryhana, additional, Mochon, A. Brian, additional, Procop, Gary W., additional, Richter, Sandra S., additional, Rychert, Jenna A., additional, Sercia, Linda, additional, and Burnham, Carey-Ann D., additional

Published
2013
Full Text
View/download PDF

11. Differing Von Hippel Lindau Genotype in Paired Primary and Metastatic Tumors in Patients with Clear Cell Renal Cell Carcinoma

Author

Vaziri, Susan A. J., primary, Tavares, Emmanuel J., additional, Golshayan, Ali R., additional, Rini, Brian I., additional, Aydin, Hakan, additional, Zhou, Ming, additional, Sercia, Linda, additional, Wood, Laura, additional, Ganapathi, Mahrukh K., additional, Bukowski, Ronald M., additional, and Ganapathi, Ram, additional

Published
2012
Full Text
View/download PDF

14. Renal Tubulocystic Carcinoma Is Closely Related to Papillary Renal Cell Carcinoma: Implications for Pathologic Classification

Author

Zhou, Ming, primary, Yang, Ximing J., additional, Lopez, Jose I., additional, Shah, Rajal B., additional, Hes, Ondrej, additional, Shen, Steven S., additional, Li, Rongshan, additional, Yang, Yu, additional, Lin, Fan, additional, Elson, Paul, additional, Sercia, Linda, additional, Magi-Galluzzi, Cristina, additional, and Tubbs, Ray, additional

Published
2009
Full Text
View/download PDF

15. Renal Angiomyolipoma

Author

Aydin, Hakan, primary, Magi-Galluzzi, Cristina, additional, Lane, Brian R., additional, Sercia, Linda, additional, Lopez, Jose I., additional, Rini, Brian I., additional, and Zhou, Ming, additional

Published
2009
Full Text
View/download PDF

20. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association.

Author

Aydin H, Magi-Galluzzi C, Lane BR, Sercia L, Lopez JI, Rini BI, and Zhou M

Subjects
Adult, Angiomyolipoma etiology, Female, Humans, Immunohistochemistry, Kidney Neoplasms etiology, Male, Middle Aged, Tuberous Sclerosis complications, Angiomyolipoma pathology, Epithelioid Cells pathology, Kidney Neoplasms pathology, Tuberous Sclerosis pathology
Abstract

The majority of renal angiomyolipoma (AML) is sporadic and occasionally it occurs as part of tuberous sclerosis complex (TSC). Epithelioid AML (EAML), an uncommon variant, is considered potentially malignant based on anecdotal case reports. The prognostic significance of epithelioid component in an otherwise typical AML is uncertain. We studied 194 AMLs for the clinicopathologic features of epithelioid and TSC-associated AMLs. Epithelioid component was present in 15 cases (7.7%) with an average amount of 51% (range: 10% to 100%). Histologically, the epithelioid tumor cells were categorized into small, intermediate, and large cell type based on the cell size. Worrisome histologic features were seen in many EAMLs, including coagulative tumor necrosis in 27% (4/15), nuclear atypia in 93% (14/15), mitosis in 47% (7/15), and atypical mitosis in 1 case. All 15 EAML patients had a mean follow-up time of 5.1 years and none had local recurrence or distant metastasis. Sixteen (8.2%) AMLs occurred in patients with definitive TSC. Three histologic features, namely microscopic AML foci, epithelioid component, and epithelial cysts, were present in 10 (62.5%), 4 (25%), and 44% (7/16), respectively, of TSC-associated AMLs, compared with 11 (6.2%), 11 (6.2%), and 6 (3.4%), respectively, in non-TSC-associated AMLs (P value all <0.01). In summary, all 15 cases of EAMLs in our study had benign clinical outcomes despite adverse pathologic features. Epithelioid component, epithelial cysts, and microscopic AML foci are strongly associated with TSC and the presence of all 3 features should raise strong suspicion for TSC.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results